• Home
  • About Steve Woodruff
  • Contact
  • About Impactiviti

Impactiviti blog

Pharma needs? Ask Steve.

Feeds:
Posts
Comments
« I love this sign
After Hours 4_28 »

Pharma News 4_28

April 28, 2008 by Steve Woodruff

Statin and Alzheimer’s…ummm, maybe not – More news from that big neurology meeting : Lipitor doesn’t help slow cognitive decline in Alzheimer’s patients, researchers said this week. That’s something of a disappointment, given that it was a big, randomized study, and earlier data had showed promise. On the other hand, Alzheimer’s patients who took Lipitor at least didn’t seem to do any worse than those who took a placebo…more

Zimmer to launch new ethical marketing practices endeavor – In what may be an effort to head off legislation, Zimmer announced new rules covering its relationships with docs, specifically, payments for consulting, gift giving and medical education funding…more

More on the proposed Massachusetts gift ban – the state Senate unanimously approved a first-in-the-nation law banning all gifts to doctors from pharmaceutical companies, but lawmakers removed a controversial provision that would have criminalized the practice…more.  And, in a similar vein – Drug and device makers shouldn’t be allowed to offer freebies – including meals, gifts, travel and ghost-writing helps – to docs, staffers and students in any or all 129 of the nation’s medical colleges, according to a new report from the Association of American Medical Colleges, which spent two years on the project.

News we can all applaud – more chocolate, better health! – Munch on dark chocolate on your way to lower cholesterol…more.  PLUS – UK study enrolling folks for a year’s worth of “chocolate therapy” to measure diabetes impact! Woo-hoo!

Glaxo jumps on red wine therapy – well, OK, sort of - Like many aging pharmaceutical companies, GlaxoSmithKline has been looking for rejuvenation. Now it thinks it might have literally found the elixir of youth. Glaxo, a British drug maker, said Tuesday it would acquire an American biotechnology company that is pursuing the notion that a compound found in red wine might retard aging and let people live longer…more

About these ads

Share this:

  • Twitter
  • StumbleUpon
  • Facebook
  • Email

Like this:

Like Loading...

Posted in Biotech, Glaxosmithkline, GSK, Marketing, Medical Devices, Medicine, Pharma, Pharma News, Pharmaceutical, Statins | Tagged Chocolate, Zimmer | 1 Comment

One Response

  1. on May 1, 2008 at 12:11 pm Kelley Eidem

    There’s a physician who was also an astronaut who suffered from global amnesia when taking Lipitor. He didn’t recognize his wife after taking a walk.

    She coaxed him into the house with milk and cookies!

    He also did not remember that he attended medical school.

    I have more about the dangers of statins on my blog.



Comments are closed.

  • Welcome!


    Steve Woodruff
    sw
    President, Impactiviti
    Pharmaceutical Connection Agent
  • Connect with Steve Woodruff


    SteveWoodruff.com
  • Testimonials


    “Steve Woodruff is one of the most “networked” people I’ve found in pharmaceutical training. His communications are always smart and targeted, and I value his professional partnership.” -Jennifer Zinn, Director, Worldwide Marketing, Clinical Laboratory, Ortho Clinical Diagnostics

    Read More Testimonials
  • Free ebook! Getting Started with Social Networking

  • Subscribe!

    Subscribe in a reader
  • Subscribe via e-mail

    Subscribe to Impactiviti blog by Email
  • Subscribe to our e-newsletter

    View our Archive
    Email Marketing by Constant Contact®

  • Bookmark



  • Recent Posts

    • Is Pharma Sales Dead?
    • We Do Everything…Just Like Everybody Else!
    • Create Your Vendor Map
    • Create Your Vendor Funnel
    • Friday Notes 3_8_13
    • Fresh Job Postings
    • On Writing Well
    • Let’s Talk
    • Successful Vendor Management – Measuring Success
    • Successful Vendor Management – Define Your Terms
  • Recent Comments

    Glen Drummond on Is Pharma Sales Dead?
    Andrew Nemiccolo (@n… on Is Pharma Sales Dead?
    DenVan on We Do Everything…Just Li…
    Steve Woodruff (@swo… on We Do Everything…Just Li…
    Steve Woodruff (@swo… on We Do Everything…Just Li…
  • Archives

    • April 2013
    • March 2013
    • February 2013
    • January 2013
    • December 2012
    • November 2012
    • October 2012
    • September 2012
    • July 2012
    • June 2012
    • May 2012
    • April 2012
    • March 2012
    • February 2012
    • January 2012
    • December 2011
    • November 2011
    • October 2011
    • September 2011
    • August 2011
    • July 2011
    • June 2011
    • May 2011
    • April 2011
    • March 2011
    • February 2011
    • January 2011
    • December 2010
    • November 2010
    • October 2010
    • September 2010
    • August 2010
    • July 2010
    • June 2010
    • May 2010
    • April 2010
    • March 2010
    • February 2010
    • January 2010
    • December 2009
    • November 2009
    • October 2009
    • September 2009
    • August 2009
    • July 2009
    • June 2009
    • May 2009
    • April 2009
    • March 2009
    • February 2009
    • January 2009
    • December 2008
    • November 2008
    • October 2008
    • September 2008
    • August 2008
    • July 2008
    • June 2008
    • May 2008
    • April 2008
    • March 2008
    • February 2008
    • January 2008
    • December 2007
    • November 2007
    • October 2007
    • September 2007
    • August 2007
    • July 2007
    • June 2007
    • May 2007
    • April 2007
    • March 2007
    • February 2007
    • January 2007
    • December 2006
    • November 2006
    • October 2006
    • September 2006
    • August 2006
    • July 2006
  • Categories

    • Abbott
    • Advertising
    • After Hours
    • Allergan
    • Amgen
    • Amylin
    • Assessment
    • AstraZeneca
    • Avandia
    • Bayer
    • Biotech
    • Blogging
    • Blogs
    • BMS
    • Boehringer Ingelheim
    • book review
    • Branding
    • Bristol Myers
    • Business
    • Career planning
    • Celgene
    • Cephalon
    • Communications
    • Conference
    • Consulting
    • Covidien
    • Daiichi Sankyo
    • Depression
    • Diabetes
    • DTC
    • eLearning
    • Eli Lilly
    • Entrepreneur
    • ePatients
    • epharma
    • Ethics
    • facebook
    • FDA
    • Forest Labs
    • Friday Collection
    • Fun
    • Genentech
    • Genzyme
    • Glaxosmithkline
    • GSK
    • Healthcare
    • Impactiviti
    • Inspiration
    • Interview
    • iPad
    • J&J
    • Job
    • Job Board
    • John Mack
    • Johnson and Johnson
    • Lilly
    • Marketing
    • Medical Devices
    • Medicine
    • Meetings
    • Merck
    • Mobile
    • Music
    • Musings
    • Networking
    • News
    • No Bad Training
    • Novartis
    • Novo Nordisk
    • Obesity
    • Oncology
    • Outsourcing
    • Parenting
    • Paul Potts
    • Personal
    • Peter Rost
    • Pfizer
    • Pharma
    • Pharma News
    • Pharmaceutical
    • Project Management
    • Purdue
    • Recommendations
    • Red Cross
    • Reviews
    • Right-sourcing
    • Roche
    • Sales
    • Sales training
    • Sanofi-Aventis
    • Scandal
    • Schering
    • Social Media
    • SPBT
    • Spoof
    • Starting a business
    • Statins
    • Takeda
    • Technology
    • The Pharma Side
    • Top News
    • Training
    • Training Needs
    • Twitter
    • Uncategorized
    • Vendor Management
    • Vendor Selection
    • Video
    • Web
    • Webinar
    • Wyeth
    • Wyth
  • Add to Technorati Favorites
    Alltop, all the top stories
  • Pages

    • About Impactiviti
    • About Steve Woodruff
    • Contact

Blog at WordPress.com.

Theme: MistyLook by WPThemes.


Follow

Get every new post delivered to your Inbox.

Powered by WordPress.com
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
%d bloggers like this: